Breo Ellipta

Breo Ellipta is a prescription medication used to prevent asthma attacks and to treat chronic obstructive pulmonary disease (COPD) in people 18 years of age and older. Breo Ellipta is available as an inhaler that you breathe in through the mouth using the Breo Ellipta inhaler device. Use this drug for a condition that is listed in this section only if it has been so prescribed by your doctor. The most common side effects with Breo Ellipta are sinus infection, sore throat, dry mouth, headache, and muscle pain or cramps. Breo Ellipta is an inhaler that combines two medicines: fluticasone furoate and vilanterol. Breo Ellipta is an inhaler that combines two medicines: fluticasone furoate and vilanterol. Fluticasone furoate is a corticosteroid, which helps to control inflammation in your airways. Vilanterol is a bronchodilator, which helps to widen the airways in your lungs. Fluticasone furoate is a corticosteroid that reduces inflammation in the lungs. Fluticasone furoate is a corticosteroid that reduces inflammation in the lungs. It is used to treat asthma and chronic obstructive pulmonary disease (COPD). Fluticasone furoate is a long-term medication, which means you need to take it every day for your condition to stay under control. You may not notice any changes after you start taking fluticasone furoate until your symptoms start getting better. You will likely need this medicine for several months before it works well enough for you to feel safe without needing an inhaler or rescue medicine for asthma attacks. Vilanterol is a bronchodilator that works by relaxing the muscles surrounding the airways, thereby widening them. Breo Ellipta is a long-acting bronchodilator, used to treat COPD and asthma. It works by relaxing the muscles surrounding the airways, thereby widening them. This allows more air to flow into your lungs, and helps you breathe more easily. The medicine should be administered once daily via a dry powder inhaler (DPI) device that contains 200µg of vilanterol tartrate or 100µg of fluticasone furoate monohydrate in each dose. The DPI device should be used every day at approximately the same time each morning with or without food for maximum efficacy and to avoid side effects such as coughing and throat irritation from using it too much. This medication should not be used to treat sudden asthma attacks or COPD flare ups. Breo Ellipta should not be used to treat sudden asthma attacks or COPD flare ups. If you have sudden symptoms of asthma, see your doctor right away. This medication can be taken with other medications that help control breathing problems like corticosteroids (e.g., budesonide) and long-acting beta2 agonists (e.g., salmeterol). The safety and effectiveness of Breo Ellipta when taken with these types of medications have not been established in clinical trials.